Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ramping up competition ...

The FDA re-approved Wellcovorin, a drug from GSK, that the company stopped selling more than 25 years ago, as part of a push from the Trump administration to identify the causes of and potential ...

Prescription weight loss medications have become more popular in recent years, including medications like Ozempic and Wegovy.

Pfizer acquires Metsera for up to $7.3B, aiming to enter the high-growth obesity drug market and diversify its portfolio.

Recently, a different weight loss drug, ecnoglutide, with an active ingredient of the peptide ecnoglutide, has been utilized ...

The clinical trial that Eli Lilly terminated was expected to enroll 180 people and finish in late 2026. The trial had been measuring how well Bimagrumab stimulates weight loss and preserves muscle ...

A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

The decision to stop the Phase IIb study was driven by “strategic business reasons,” according to a federal clinical trials ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

He recalled a personal story about someone in his neighborhood. Cam’ron compared Williamson’s physical shift to a drug user getting clean. He pointed out that while the man’s wit and humor were ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in ...